Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Crescita Therapeutics Inc CRRTF


Primary Symbol: T.CTX

Healthcare
Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties and Manufacturing and Services. The Commercial... see more

Showcase News Releases

Showcase news

Lithium Ionic Corp
Lithium Ionic Files NI 43-101 Technical Report for the Salinas Lithium Project Mineral Resource Estimate, Minas Gerais, Brazil
NurExone Biologic Inc.
NurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive Strategic Collaborations
Hillcrest Energy Technologies Ltd.
Hillcrest Announces New Joint Development Opportunity and Provides Additional Shareholder Updates

More Showcase News Releases »